201282-04-4,MFCD24466192
Catalog No.:AA01FNJR

201282-04-4 | Carbamic acid, [6-[(chloroacetyl)amino]hexyl]-, 1,1-dimethylethyl ester

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
2 weeks  
$249.00   $175.00
- +
250mg
95%
2 weeks  
$400.00   $280.00
- +
1g
95%
2 weeks  
$922.00   $646.00
- +
2.5g
95%
2 weeks  
$1,493.00   $1,045.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01FNJR
Chemical Name:
Carbamic acid, [6-[(chloroacetyl)amino]hexyl]-, 1,1-dimethylethyl ester
CAS Number:
201282-04-4
Molecular Formula:
C13H25ClN2O3
Molecular Weight:
292.8022
MDL Number:
MFCD24466192
SMILES:
ClCC(=O)NCCCCCCNC(=O)OC(C)(C)C
Properties
Computed Properties
 
Complexity:
278  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
10  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
2.3  

Downstream Synthesis Route

[1]Prandina,Anthony;Radix,Sylvie;LeBorgne,Marc;Jordheim,LarsPetter;Bousfiha,Zineb;Fröhlich,Christopher;Leiros,Hanna-KirstiS.;Samuelsen,Ørjan;Frøvold,Espen;Rongved,Pål;Åstrand,OveAlexanderHøgmoen[Tetrahedron,2019,vol.75,#11,p.1525-1540]

[2]CurrentPatentAssignee:DANA-FARBERCANCERINSTITUTE-WO2017/24317,2017,A2Locationinpatent:Page/Pagecolumn308;309

[3]CurrentPatentAssignee:DANA-FARBERCANCERINSTITUTE-US2016/176916,2016,A1Locationinpatent:Paragraph0711-0713

[4]CurrentPatentAssignee:DANA-FARBERCANCERINSTITUTE-WO2018/148440,2018,A1Locationinpatent:Page/Pagecolumn387

[5]CurrentPatentAssignee:DANA-FARBERCANCERINSTITUTE-WO2018/148443,2018,A1Locationinpatent:Page/Pagecolumn368

[6]CurrentPatentAssignee:LeicaMicrosystems(in:Danaher);DANAHERCORP-US9188590,2015,B2Locationinpatent:Page/Pagecolumn33

[7]Dredar,SasiA.;Blankenship,JamesW.;Marchant,PamelaE.;Manneh,Victor;Fries,DavidS.[JournalofMedicinalChemistry,1989,vol.32,#5,p.984-989]

[8]Du,Zhangli;Borlace,GlennN.;Brooks,RobertD.;Butler,RossN.;Brooks,DougA.;Plush,SallyE.[InorganicaChimicaActa,2014,vol.410,p.11-19]

[9]CurrentPatentAssignee:ASTRAZENECAPLC-WO2014/106128,2014,A1Locationinpatent:Paragraph0146

201282-04-4   
N-(Chloroacetyl)-1,6-diaminohexanehydrochloride 

[1]Dredar,SasiA.;Blankenship,JamesW.;Marchant,PamelaE.;Manneh,Victor;Fries,DavidS.[JournalofMedicinalChemistry,1989,vol.32,#5,p.984-989]

288302-12-5    201282-04-4   
25,27-bisN-(tert-butoxycarbonyl)-6-aminohexyl-1-(aminocarbonyl)methoxy-5,11,17,23-tetrakis(1,1-dimethylethyl)-26,28-bis(hydroxy)calix4arene 

[1]VanDerVeen,NielsJ.;Flink,Simon;Deij,MennoA.;Egberink,RichardJ.M.;VanVeggel,FrankC.J.M.;Reinhoudt,DavidN.[JournaloftheAmericanChemicalSociety,2000,vol.122,#25,p.6112-6113]

[1]Dredar,SasiA.;Blankenship,JamesW.;Marchant,PamelaE.;Manneh,Victor;Fries,DavidS.[JournalofMedicinalChemistry,1989,vol.32,#5,p.984-989]

201282-04-4    122555-91-3   
1,4,7-Tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane-10-N-((6-tert-butoxycarbonylamino)hexyl)acetamide 

[1]InorganicaChimicaActa,2014,vol.410,p.11-19

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:201282-04-4 Molecular Formula|201282-04-4 MDL|201282-04-4 SMILES|201282-04-4 Carbamic acid, [6-[(chloroacetyl)amino]hexyl]-, 1,1-dimethylethyl ester
Catalog No.: AA01FNJR
201282-04-4,MFCD24466192
201282-04-4 | Carbamic acid, [6-[(chloroacetyl)amino]hexyl]-, 1,1-dimethylethyl ester
Pack Size: 100mg
Purity: 95%
2 weeks
$249.00 $175.00
Pack Size: 250mg
Purity: 95%
2 weeks
$400.00 $280.00
Pack Size: 1g
Purity: 95%
2 weeks
$922.00 $646.00
Pack Size: 2.5g
Purity: 95%
2 weeks
$1,493.00 $1,045.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01FNJR
Chemical Name: Carbamic acid, [6-[(chloroacetyl)amino]hexyl]-, 1,1-dimethylethyl ester
CAS Number: 201282-04-4
Molecular Formula: C13H25ClN2O3
Molecular Weight: 292.8022
MDL Number: MFCD24466192
SMILES: ClCC(=O)NCCCCCCNC(=O)OC(C)(C)C
Properties
Complexity: 278  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 19  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 10  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 2.3  
Downstream Synthesis Route
51857-17-1    79-04-9    201282-04-4 

[1]Prandina,Anthony;Radix,Sylvie;LeBorgne,Marc;Jordheim,LarsPetter;Bousfiha,Zineb;Fröhlich,Christopher;Leiros,Hanna-KirstiS.;Samuelsen,Ørjan;Frøvold,Espen;Rongved,Pål;Åstrand,OveAlexanderHøgmoen[Tetrahedron,2019,vol.75,#11,p.1525-1540]

[2]CurrentPatentAssignee:DANA-FARBERCANCERINSTITUTE-WO2017/24317,2017,A2Locationinpatent:Page/Pagecolumn308;309

[3]CurrentPatentAssignee:DANA-FARBERCANCERINSTITUTE-US2016/176916,2016,A1Locationinpatent:Paragraph0711-0713

[4]CurrentPatentAssignee:DANA-FARBERCANCERINSTITUTE-WO2018/148440,2018,A1Locationinpatent:Page/Pagecolumn387

[5]CurrentPatentAssignee:DANA-FARBERCANCERINSTITUTE-WO2018/148443,2018,A1Locationinpatent:Page/Pagecolumn368

[6]CurrentPatentAssignee:LeicaMicrosystems(in:Danaher);DANAHERCORP-US9188590,2015,B2Locationinpatent:Page/Pagecolumn33

[7]Dredar,SasiA.;Blankenship,JamesW.;Marchant,PamelaE.;Manneh,Victor;Fries,DavidS.[JournalofMedicinalChemistry,1989,vol.32,#5,p.984-989]

[8]Du,Zhangli;Borlace,GlennN.;Brooks,RobertD.;Butler,RossN.;Brooks,DougA.;Plush,SallyE.[InorganicaChimicaActa,2014,vol.410,p.11-19]

[9]CurrentPatentAssignee:ASTRAZENECAPLC-WO2014/106128,2014,A1Locationinpatent:Paragraph0146

201282-04-4   
N-(Chloroacetyl)-1,6-diaminohexanehydrochloride 

[1]Dredar,SasiA.;Blankenship,JamesW.;Marchant,PamelaE.;Manneh,Victor;Fries,DavidS.[JournalofMedicinalChemistry,1989,vol.32,#5,p.984-989]

288302-12-5    201282-04-4   
25,27-bisN-(tert-butoxycarbonyl)-6-aminohexyl-1-(aminocarbonyl)methoxy-5,11,17,23-tetrakis(1,1-dimethylethyl)-26,28-bis(hydroxy)calix4arene 

[1]VanDerVeen,NielsJ.;Flink,Simon;Deij,MennoA.;Egberink,RichardJ.M.;VanVeggel,FrankC.J.M.;Reinhoudt,DavidN.[JournaloftheAmericanChemicalSociety,2000,vol.122,#25,p.6112-6113]

124-09-4    201282-04-4 

[1]Dredar,SasiA.;Blankenship,JamesW.;Marchant,PamelaE.;Manneh,Victor;Fries,DavidS.[JournalofMedicinalChemistry,1989,vol.32,#5,p.984-989]

201282-04-4    122555-91-3   
1,4,7-Tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane-10-N-((6-tert-butoxycarbonylamino)hexyl)acetamide 

[1]InorganicaChimicaActa,2014,vol.410,p.11-19

Building Blocks More >
909398-18-1
909398-18-1
5-Octa-1-7-diynyl-2’-deoxyuridine
AA01FNVN
57991-39-6
57991-39-6
Sodium Cyanide-13C
AA01FNYZ
298682-21-0
298682-21-0
2-(3-Methyl-4-oxo-3,4-dihydrophthalazin-1-yl)propanoic acid
AA01FO26
107622-07-1
107622-07-1
[2-(2-Phenylethyl)phenyl]aminehydrochloride
AA01FO4W
328025-23-6
328025-23-6
N-(2,4-Dichlorophenyl)-4-hydrazino-4-oxobutanamide
AA01FO7Q
1138444-94-6
1138444-94-6
1-Chloro-4-(1,1-difluoroethyl)-2-(trifluoromethyl)benzene
AA01FOB3 | MFCD11845801
887029-19-8
887029-19-8
N-(3,4-Dimethylphenyl)-3-methyl-2-(1H-pyrrol-1-yl)butanamide
AA01FODL
415943-39-4
415943-39-4
2-(2-Allylphenoxy)acetohydrazide
AA01FOGG
865658-90-8
865658-90-8
9,11-dibromo-5,6-dihydrobenzo[c]acridine
AA01FOJT
338417-33-7
338417-33-7
N-[1-(2,4-dichlorobenzyl)-1H-1,2,3,4-tetraazol-5-yl]-N,N-dimethylamine
AA01FON1
Submit
© 2017 AA BLOCKS, INC. All rights reserved.